Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

IFRD1 modulates disease severity in cystic fibrosis through the regulation of neutrophil effector function

1 Aug 2009

Abstract excerpt

Identification of IFRD1 as a modifier gene for cystic fibrosis lung disease Gu et al. (2009) Nature 458: 1039–1044

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cystic Fibrosis Research Advances
Share to Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Share to Neonatal Respiratory Health Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 19673948
DOI: 10.1111/j.1399-0004.2009.01247_2.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

IFRD1 modulates disease severity in cystic fibrosis through the regulation of neutrophil effector functionPMID 19673948Read ↗

Identification of IFRD1 as a modifier gene for cystic fibrosis lung disease.Semantic proximity Read ↗

Expression and regulation of interferon-related development regulator-1 in cystic fibrosis neutrophils.Semantic proximity Read ↗

Lung disease modifier genes in cystic fibrosisSemantic proximity Read ↗

Immunomodulatory function of the cystic fibrosis modifier gene BPIFA1.Semantic proximity Read ↗

SPLUNC1 is a novel marker of disease severity and airway infection in bronchiectasisSemantic proximity Read ↗

Genetic Modifiers of Cystic Fibrosis Lung Disease Severity: Whole-Genome Analysis of 7,840 PatientsSemantic proximity Read ↗

PDZ Structure and Implication in Selective Drug Design against Cystic Fibrosis.Semantic proximity Read ↗

FAM13A is a modifier gene of cystic fibrosis lung phenotype regulating rhoa activity, actin cytoskeleton dynamics and epithelial-mesenchymal transition.Semantic proximity Read ↗

IFRD1 gene polymorphisms are associated with nasal polyposis in cystic fibrosis patients.Semantic proximity Read ↗

In silico search for modifier genes associated with pancreatic and liver disease in Cystic Fibrosis.Semantic proximity Read ↗

DLK1 downregulation serves as a potential biomarker for disease severity and a therapeutic target in bronchiectasisSemantic proximity Read ↗

CFTR modulators exert subset-specific phenotype remodeling on circulating neutrophils in cystic fibrosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.